Vic pharma manufacturer expands operations
21 June, 2019Australian Pharmaceutical Manufacturers has opened expanded operations in the suburb of Keysborough, allowing the company to increase exports and create 44 new local jobs.
'Homing beacon' attracts chemo drugs to tumours
20 June, 2019Scientists have added a 'homing beacon' to tumours, in the form of an injectable hydrogel, that attracts chemotherapy medicines towards cancer cells while sparing their normal counterparts.
New drug candidate for active rheumatoid arthritis
17 June, 2019In a large-scale, international study, 12.5 to 20% of patients who were given the drug on a daily basis experienced so-called sustained remission — a state that is almost like being cured.
Universal flu vaccine passes development milestones
14 June, 2019Vaccitech has administered its pandemic universal influenza A vaccine MVA-NP+M1 (VTP-100) to the first participants in a Flu 010 study.
Cannabis for cancer treatment on the agenda
07 June, 2019MGC Pharmaceuticals has been granted a cannabis research licence in tandem with RMIT University, while Medlab Clinical has executed a heads of agreement for the further global distribution of its CBD/THC blend.
Synthetic molecules deliver drugs directly to neuroblastoma
06 June, 2019Researchers synthesised a family of molecules that are able to specifically bind a protein found in the cell membrane of more than 90% of neuroblastoma cells.
Stem cell therapy can reverse osteoarthritis
05 June, 2019Pure stem cells provide a more effective treatment for osteoarthritis than traditional therapies, such as pain relief drugs, anti-inflammatories, prescribed exercise and knee surgery.
Cell culture platform recreates tumours in 3D
29 May, 2019Scientists can use a 3D tumour structure to test several drugs or their combinations at different stages of the tumour's development.
Scientists combine influenza and pneumococcal vaccines
23 May, 2019Scientists have developed a single vaccination approach to simultaneously combat influenza and pneumococcal infections, while enhancing protection against both.
Biological tissue could be 3D printed
21 May, 2019Researchers have been working to develop and optimise suitable bioinks for additive manufacturing, in the hope that we will soon be using 3D-printed biologically functional tissue to replace irreparably damaged tissue in the body.
Synthetic polymyxin antibiotics could take on superbugs
16 May, 2019Monash University has granted an exclusive licence of its portfolio of proprietary synthetic polymyxin antibiotics to Qpex Biopharma.
Cancer cells tricked into defective reproduction
15 May, 2019A 'triple combination' of vitamin C and two standard antibiotics — doxycycline and azithromycin — was sufficient to reduce stem cell growth by more than 90% in laboratory tests.
DNA folded into a nanocapsule for drug delivery
01 May, 2019Finnish researchers have developed a customised DNA nanostructure that can perform a predefined task in human body-like conditions.
Natural antibiotic genetically engineered from fungus
15 April, 2019Researchers have used genetic engineering to turn a fungus into a natural antibiotic — one which could serve as a promising cure for a neglected tropical disease.
Ovarian cancer trial shows positive results
11 April, 2019Kazia Therapeutics has summarised data from Part A of its ongoing phase I study of Cantrixil in ovarian cancer — a study which has so far seen promising results.
